About the 2025 latest price and purchasing methods of Roflumilast-DALIRESP
Roflumilast - The primary indication for DALIRESP is the treatment of severe chronic obstructive pulmonary disease (COPD), which affects the lungs and airways and causes persistent difficulty breathing and other related symptoms. Roflumilast is a phosphodiesterase 4 (PDE4) inhibitor that helps reduce the frequency and severity of COPD symptoms by reducing inflammation and swelling in the lungs. It is not suitable for the relief of acute bronchospasm and therefore requires long-term use under the guidance of a physician.
Roflumilast is available as an oral tablet and is generally recommended for patients to take once daily, with or without food. To ensure optimal effectiveness of the drug, patients are advised to take it at the same time every day. This regular way of taking medication can help maintain stable drug concentrations in the body, thereby improving the therapeutic effect. During use, patients should strictly follow the doctor's prescription and avoid increasing or decreasing the dosage at will to ensure safety and effectiveness.
As for the price and purchase methods of roflumilast, as of now (May 2025), the drug has not yet been officially launched in the Chinese market, so its official selling price and medical insurance-related information are still unknown. However, China's Hong Kong original research version is already on the market. Each box of 500mcg*30 tablets is priced at about 2,500 yuan. The specific price will vary due to exchange rate fluctuations and other factors. In addition, there are also imitation versions produced in overseas markets. For example, roflumilast produced by an Indian pharmaceutical factory has a specification of 500mcg*100 tablets and is sold for about 400 yuan per box. This price is also affected by exchange rate changes.
For patients who wish to purchase roflumilast, they can consult and purchase through overseas channels such as hospitals and pharmacies. When choosing medicines, be sure to ensure that the products you purchase come from legal and compliant sources to avoid counterfeit and shoddy products that may harm your health.
Reference materials:https://medlineplus.gov/druginfo/meds/a611034.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)